Volume 4, Issue 1 (January 2025)                   Health Science Monitor 2025, 4(1): 1-6 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Tahir D, Bhatti I H, Tariq W, Ginnaram S, Lipkin J. Unraveling a case of pantoprazole-induced-anaphylaxis requiring tracheostomy: A case report. Health Science Monitor 2025; 4 (1) :1-6
URL: http://hsm.umsu.ac.ir/article-1-202-en.html
Internal Medicine, Jefferson Abington Hospital, Abington, Pennsylvania, USA
Abstract:   (658 Views)

Background:  Proton pump inhibitors (PPIs) are used by 50.85%, 42.16%, and 40.97% of doctors, nurses, and pharmacists, respectively. The reported incidence of anaphylaxis with PPIs is under 1%.
Case Presentation: We present the first-ever reported case of anaphylaxis to pantoprazole, which failed medical management with multiple attempts for endotracheal and nasotracheal intubation failed due to diffuse edema, necessitating the need for an urgent tracheostomy and mechanical ventilation. Famotidine replaced pantoprazole throughout the hospital course, and he had no further hypersensitivity reactions.  
Conclusion: PPIs are effective but not without severe complications. Unfortunately, anaphylaxis is often misdiagnosed, increasing the risk of mortality and morbidity. Although anaphylaxis is rare, these reactions can be life-threatening. Emergency medicine and primary care physicians must be aware of the potential side effects of PPIs and should carefully monitor patients in inpatient and outpatient clinical settings.

Full-Text [PDF 273 kb]   (267 Downloads)    
Type of Study: case report | Subject: General
Received: 2024/10/5 | Accepted: 2024/12/21 | Published: 2025/02/27

References
1. Luo H, Fan Q, Bian T, Li X, Chen K, Zhang Q, et al. Awareness, attitude and behavior regarding proton pump inhibitor among medical staff in the Southwest of China. BioMed Central Health Services Research. 2019 Nov 21;19(1):880. doi: 10.1186/s12913-019-4725-6. [DOI] [PMID] [PMCID]
2. James J, Rani J, Sathyanarayanan V, Begum A, Fayaz SH. Anaphylaxis to Pantoprazole: A Case Report and Prerequisite for Vigilant Prescribing Practises for Proton Pump Inhibitors. Current Drug Safety. 2022;17(1):78-80. doi: 10.2174/1574886316666210728115356. [DOI] [PMID]
3. Telaku S, Veliu A, Zenelaj Q, Telaku M, Fejza H, Alidema F. Anaphylaxis Caused by Taking Pantoprazole: Case Series. European Journal of Case Reports in Internal Medicine. 2023;10(9):004017. doi: 10.12890/2023_004017. [DOI] [PMID] [PMCID]
4. Savarino V, Marabotto E, Zentilin P, Furnari M, Bodini G, De Maria C, et al. The appropriate use of proton-pump inhibitors. Minerva Medica. 2018;109(5):386-399. doi: 10.23736/S0026-4806.18.05705-1. Epub 2018 May 31. [DOI] [PMID]
5. Zeng M, Li Y, Chen T, Zhang S, Luo H. Evolution of proton pump inhibitor prescribing from 2017 to 2021 at 14 secondary and tertiary hospitals in China: a multicentre cross-sectional study. British Medical Journal Open. 2023;13(7):e072793 . doi: 10.1136/bmjopen-2023-072793. [DOI] [PMID] [PMCID]
6. Mishuk AU, Chen L, Gaillard P, Westrick S, Hansen RA, Qian J. National trends in prescription proton pump inhibitor use and expenditure in the United States in 2002-2017. Journal of the American Pharmacists Association. 2020 22:S1544-3191 (20)30476-3. doi: 10.1016/j.japh.2020.09.015. Epub ahead of print. [DOI] [PMID]
7. Cheer SM, Prakash A, Faulds D, Lamb HM. Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders. Drugs. 2003;63(1):101-33. doi: 10.2165/00003495-200363010-00006. [DOI] [PMID]
8. Mathews S, Reid A, Tian C, Cai Q. An update on the use of pantoprazole as a treatment for gastroesophageal reflux disease. Clinical and Experimental Gastroenterology. 2010;3:11-6. doi: 10.2147/ceg.s6355. Epub 2010 Jan 20. [DOI] [PMID] [PMCID]
9. Fitton A, Wiseman L. Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders. Drugs. 1996;51(3):460-82. doi: 10.2165/00003495-199651030-00012. Erratum in: Drugs 1996 Jul;52(1):92. Erratum in: Drugs 1996 Jun;51(6):1074. [DOI] [PMID]
10. Martín de Argila C. Safety of potent gastric acid inhibition. Drugs. 2005;65 Suppl 1:97-104. doi: 10.2165/00003495-200565001-00013. [DOI] [PMID]
11. Devault KR. Pantoprazole: a proton pump inhibitor with oral and intravenous formulations. Expert Review of Gastroenterology & Hepatology. 2007;1(2):197-205. doi: 10.1586/17474124.1.2.197. [DOI] [PMID]
12. Song WJ, Kim MH, Lee SM, Kwon YE, Kim SH, Cho SH, et al. Two cases of h(2)-receptor antagonist hypersensitivity and cross-reactivity. Allergy, Asthma & Immunology Research. 2011;3(2):128-31. doi: 10.4168/aair.2011.3.2.128. Epub 2010 Sep 6. [DOI] [PMID] [PMCID]
13. Untersmayr E. Acid suppression therapy and allergic reactions. Allergo Journal International. 2015;24(8):303-311. [DOI] [PMID] [PMCID]
14. Bernshteyn MA, Masood U. Pantoprazole. [Updated 2023 Jul 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK499945/ [Google Books]
15. Faridaalaee G, Ahmadian Heris J. Anaphylaxis as a Rare Side Effect of Pantoprazole; a Case Report. Emergency (Tehran). 2018;6(1):e34 . Epub 2018 May 21. [Google Scholar]
16. Lai HC, Hsu SW, Lu CH, Ma HI, Cherng CH, Hung NK, et al. Anaphylaxis to pantoprazole during general anesthesia. Journal of Anesthesia. 2011;25(4):606-8. doi: 10.1007/s00540-011-1148-x. Epub 2011 May 29. [DOI] [PMID]
17. Yadav A, Das I, Yadav D. A rare case of pantoprazole induced anaphylactic shock. Current Research. 2019;11:7522-7523. https://journalcra.com/sites/default/files/issue-pdf/34901.pdf [Google Scholar]
18. Alolabi R, Liem JJ. Pantoprazole-induced anaphylaxis. Journal of Allergy and Clinical Immunology. 2019;143:AB73 . [DOI] [PMID] [PMCID]
19. Bahuguna R, Joshi D, Rana M. A case report on allergic reaction to pantoprazole. International Journal of Science and Healthcare Research. 2021;6:82-86. [DOI]
20. Yousefi H, Moayedi S, Harorani M, Sahebi A, Golitaleb M. Anaphylaxis as a side effect of pantoprazole. Shiraz E-Medical Journal. 2020;21:e97458 . http://dx.doi.org/10.5812/semj.97458 [DOI]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 All Rights Reserved | Health Science Monitor

Designed & Developed by : Yektaweb